Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure
Heart failure (HF) is a shared manifestation of several cardiovascular pathologies, including hypertension and myocardial infarction, and a limited repertoire of treatment modalities entails that the associated morbidity and mortality remain high. Impaired nitric oxide (NO)/guanylyl cyclase (GC)/cyc...
Главные авторы: | Baliga, RS, Preedy, MEJ, Dukinfield, MS, Chu, SM, Aubdool, AA, Bubb, KJ, Moyes, AJ, Tones, MA, Hobbs, AJ |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
National Academy of Sciences
2018
|
Схожие документы
-
Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways.
по: Padovan-Neto, F, и др.
Опубликовано: (2015) -
Possible regulation of cardiac ADP-ribosyl cyclase by cGMP-dependent mechanisms
по: Solanki, P, и др.
Опубликовано: (2000) -
cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology.
по: Zaccolo, M, и др.
Опубликовано: (2007) -
Guanylyl cyclase C prevents colon carcinoma cell metastasis.
по: Lubbe, W, и др.
Опубликовано: (2005) -
cGMP-phosphodiesterase inhibition prevents hypoxia-induced cell death activation in porcine retinal explants
по: Olivares-González, L, и др.
Опубликовано: (2016)